(Q80970124)
Statements
Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial (English)
K J Dedes
T D Szucs
P Imesch
A Fedier
M K Fehr
scientific article published on 01 September 2007